Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyapatite and collagen matrix is the fundamental composite material of vertebrate bone, comprising an organic framework of Type I collagen fibers and an inorganic phase of calcium phosphate crystals (Wahl & Czernuszka, 2006). This matrix provides the mechanical strength and structural integrity required for the skeletal system while also serving as a reservoir for essential minerals like calcium and phosphate (Glimcher, 2006). In regenerative medicine, synthetic or processed versions of this matrix are utilized as osteoconductive scaffolds that facilitate the migration and attachment of bone-forming cells (Ferreira et al., 2020). The hydroxyapatite component is a critical pharmacological target for bisphosphonates, which bind to the mineral surface to inhibit osteoclast-mediated bone resorption in conditions like osteoporosis (Russell, 2007). Furthermore, the collagenous component provides essential motifs that interact with integrin receptors on the surface of mesenchymal stem cells to promote osteogenic differentiation (Heino, 2007). Therapeutic interventions often involve loading this matrix with growth factors, such as bone morphogenetic proteins (BMPs), to enhance its osteoinductive potential (Infante & Rodriguez, 2018). As a biomaterial, it is extensively used in orthopedic and dental surgeries to fill bone voids and promote natural healing (Wahl & Czernuszka, 2006). The degradation and remodeling of this matrix are tightly regulated by the balanced activity of osteoblasts and osteoclasts, making it a central focus for treating metabolic bone diseases (Russell, 2007).
Provides a structural scaffold for osteoconduction and serves as a high-affinity binding site for bone-seeking minerals and drugs.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite and Collagen Matrix (HAp/Col).